77F-23695-67675
4 vaccinations
1 coded response
42 check-ins
1 free-text entry
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 604 / IL
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Not Hispanic or Latino
Registered dependents
QUM-32134-58579
Child or adolescent in my care · Male · 2022-06-25
AYN-68122-66549
Child or adolescent in my care · Male · 2022-06-25
Timeline
-
2020-12-20
Dose 1 — Pfizer-BioNTech
-
2021-01-09
Registered in v-safe
-
2021-01-09
Dose 2 — Pfizer-BioNTech
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Redness, Swelling · Chills, Headache, Joint pains, Muscle or body aches · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-01-16
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
-
2021-01-23
Survey response — day 14, dose 2MedDRA: Chills, Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headaches, chills and FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-12
-
2021-09-28
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-12-28
- 2022-03-29
-
2022-09-28
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-28
- 2022-09-28
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, HeadacheAdult check-in
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-12-28
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-28 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-10 | priority 2/3 | |
| 2021-01-12 | priority 2/3 | |
| 2021-01-13 | priority 2/3 |
Free text
Release 2 — day 14, dose 2
Symptoms: Headaches, chills and Fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release